Write your message
Volume 24, Issue 5 (December & January 2021)                   J Arak Uni Med Sci 2021, 24(5): 640-645 | Back to browse issues page


XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Azadeh S S, Keshmiri Neghab H. The Potential of the Use of the Flavonoid Fisetin in the Treatment of Coronavirus by Inhibition of Angiotensin Converting Enzyme 2. J Arak Uni Med Sci 2021; 24 (5) :640-645
URL: http://jams.arakmu.ac.ir/article-1-6362-en.html
1- Department of Biology, Faculty of Basic Sciences, Sciences and Research Branch, Islamic Azad University, Tehran, Iran. , sara.azadehhh@gmail.com
2- Department of Photo Healing and Regeneration, Medical Laser Research Center, Yara Institute Academic Center for Education, Culture and Research, Tehran, Iran.
Abstract:   (1070 Views)
In December 2019, a new type of coronavirus called COVID-19 was identified as an unknown cause of pneumonia in Wuhan, China. The pandemic virus was transmitted to humans from a type of seafood that could spread significantly among humans in a short time. Clinical signs of coronaviruses include fever, severe sweating, cough, pneumonia, and a weakened immune system, with acute cases leading to death. One of the most important coronavirus receptors in the host cell is the angiotensin 2 converting enzyme. It is noteworthy that the patient’s recovery process increases during the inhibition of angiotensin 2 converter enzyme. Therefore, the administration of drugs that inhibit this enzyme can be effective in recovering a patient with coronavirus. Flavonoids are one the inhibitors of the angiotensin-converting enzyme, which is abundant in fruits and vegetables. Fistula, a type of flavonoid known in nature as an antioxidant and anti-inflammatory agent in the treatment of many, can be effective in the treatment of coronavirus by inhibiting the enzyme converter angiotensin 2.
Full-Text [PDF 2031 kb]   (142 Downloads) |   |   Full-Text (HTML)  (218 Views)  
Type of Study: Editorial | Subject: COVID-19
Received: 2020/06/15 | Accepted: 2021/08/8

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2023 CC BY-NC 4.0 | Journal of Arak University of Medical Sciences

Designed & Developed by : Yektaweb